Table 4 Associations between patient characteristics and treatment satisfaction
Factor | Effectiveness Median [Q1-Q3] | P value | Side effects Median [Q1-Q3] | P value | Convenience Median [Q1-Q3] | P value | Global satisfaction Median [Q1-Q3] | P value |
|---|---|---|---|---|---|---|---|---|
Age (years) | 0.301 | 0.185 | 0.230 | 0.140 | ||||
< 45 | 66.67 [55.56–72.22] | 71.88 [43.75–87.50] | 66.67 [61.11–75.00] | 71.43 [42.86–71.43] | ||||
45–65 | 66.67 [61.11–77.78] | 81.25 [43.75–100.00] | 66.67 [66.67–72.22] | 71.43 [64.29–78.57] | ||||
> 65 | 66.67 [61.11–76.39] | 90.63 [68.75–100.00] | 66.67 [66.67–76.39] | 71.43 [57.14–76.79] | ||||
Body mass index | ||||||||
< 18.5 | 66.67 | 56.25 | 75.00 | 85.72 | ||||
18.5–24.9 | 66.67 [61.11–75.00] | 87.5 [56.25–100.00] | 66.67 [63.89–69.45] | 71.43 [67.86–75.00] | ||||
25–29.9 | 66.67 [61.11–72.22] | 81.25 [53.13–100.00] | 66.67 [66.67–75.00] | 71.43 [57.14–71.43] | ||||
≥ 30 | 66.67 [61.11–75.00] | 75.00 [37.50–100.00] | 66.67 [66.67–72.22] | 71.43 [53.57–78.57] | ||||
Residency | 0.415 | 0.766 | 0.896 | 0.559 | ||||
City | 66.67 [61.11–72.22] | 84.38 [45.31–100.00] | 66.67 [66.67–77.78] | 71.43 [57.14–71.43] | ||||
Village | 66.67 [61.11–77.78] | 75.00 [43.75–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–78.57] | ||||
Camp | 66.67 [61.11–70.83] | 68.75 [64.06–98.44] | 66.67 [66.67–70.83] | 64.29 [51.79–71.43] | ||||
Smoking | 0.350 | 0.982 | 0.325 | 0.922 | ||||
No | 66.67 [61.11–72.22] | 78.13 [50.00–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–76.79] | ||||
Yes | 66.67 [61.11–83.33] | 75.00 [40.63–100.00] | 66.67 [66.67–77.78] | 71.43 [57.14–78.57] | ||||
University qualification | 0.646 | 0.225 | 0.385 | 0.699 | ||||
No | 66.67 [61.11–72.22] | 81.25 [56.25–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–78.57] | ||||
Yes | 66.67 [55.56–73.61] | 71.88 [35.94–100.00 | 66.67 [66.67–77.78] | 71.43 [57.14–71.43] | ||||
Work | 0.626 | 0.414 | 0.751 | 0.497 | ||||
Unemployed | 66.67 [61.11–72.22] | 75.00 [45.31–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–71.43] | ||||
Employed | 66.67 [55.56–83.33] | 87.50 [46.88–100.00] | 66.67 [61.11–77.78] | 71.43 [60.72–78.57] | ||||
Material status | 0.601 | 0.136 | 0.941 | 0.058 | ||||
Single | 66.67 [61.11–77.78] | 90.63 [67.19–100.00] | 66.67 [61.11–73.61] | 71.43 [69.65–78.57] | ||||
Married | 66.67 [61.11–72.22] | 75.00 [43.75–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–71.43] | ||||
Family history | 0.197 | 0.096 | 0.324 | 0.451 | ||||
No | 66.67 [61.11–77.78] | 75.00 [43.75–93.75] | 66.67 [61.11–69.45] | 71.43 [57.14–78.57] | ||||
Yes | 66.67 [61.11–72.22] | 87.50 [50.00–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–71.43] | ||||
Comorbidities | 0.543 | 0.750 | 0.685 | 0.010 | ||||
No | 66.67 [61.11–72.22] | 75.00 [43.75–100.00] | 66.67 [66.67–77.78] | 71.43 [57.14–71.43] | ||||
Yes | 66.67 [61.11–77.78] | 78.13 [48.44–100.00] | 66.67 [66.67–72.22] | 71.43 [64.29–78.57] | ||||
Chronic medication | 0.911 | 0.862 | 0.799 | 0.618 | ||||
No | 66.67 [61.11–72.22] | 75.00 [43.75–100.00] | 66.67 [66.67–77.78] | 71.43 [57.14–71.43] | ||||
Yes | 66.67 [61.11–77.78] | 78.13 [48.44–100.00] | 66.67 [66.67–72.22] | 71.43 [64.29–78.57] | ||||
Side effects (currently) | 0.523 | 0.001 | 0.766 | 0.153 | ||||
No | 66.67 [61.11–76.39] | 100.00 [57.81–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–71.43] | ||||
Yes | 66.67 [61.11–72.22] | 68.75 [40.63–87.50] | 66.67 [63.89–72.22] | 71.43 [64.29–78.57] | ||||
Number of clinic visits per year | ||||||||
< 12 | 66.67 [61.11–76.39] | 75.00 [57.81–98.44] | 66.67 [66.67–77.78] | 71.43 [64.29–78.57] | ||||
= > 12 | 66.67 [61.11–72.22] | 81.25 [43.75–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–75.00] | ||||
Hospitalized in the last year | 0.329 | 0.030 | 0.972 | 0.154 | ||||
No | 66.67 [61.11–72.22] | 87.50 [50.00–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–71.43] | ||||
Yes | 66.67 [61.11–77.78] | 65.63 [32.81–93.75] | 66.67 [61.11–76.39] | 71.43 [66.08–78.57] | ||||
Breast surgery | 0.596 | 0.249 | 0.239 | 0.782 | ||||
No | 66.67 [61.11–72.22] | 90.63 [56.25–100.00] | 66.67 [66.67–76.39] | 71.43 [58.93–78.57] | ||||
Yes | 66.67 [61.11–77.78] | 75.00 [43.75–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–75.00] | ||||
Radiotherapy | 0.746 | 0.577 | 0.679 | 0.249 | ||||
No | 66.67 [61.11–77.78] | 75.00 [37.50–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–78.57] | ||||
Yes | 66.67 [61.11–72.22] | 81.25 [56.25–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–71.43] | ||||
Chemotherapy | 0.262 | 0.636 | 0.183 | 0.607 | ||||
No | 66.67 [56.95–70.83] | 78.13 [56.25–100.00] | 66.67 [66.67–76.39] | 71.43 [51.79–71.43] | ||||
Yes | 66.67 [61.11–75.00] | 75.00 [43.75–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–78.57] | ||||
Biological therapy | 0.222 | 0.651 | 0.648 | 0.348 | ||||
No | 66.67 [61.11–77.78] | 75.00 [50.00–100.00] | 66.67 [66.67–76.39] | 71.43 [57.14–78.57] | ||||
Yes | 66.67 [51.39–70.83] | 71.88 [39.06–100.00] | 66.67 [66.67–76.39] | 71.43 [51.79–71.43] | ||||
Targeted therapy | 0.693 | 0.693 | 0.863 | 0.453 | ||||
No | 66.67 [61.11–72.22] | 81.25 [50.00–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–71.43] | ||||
Yes | 66.67 [61.11–77.78] | 65.63 [39.06–100.00] | 66.67 [66.67–76.39] | 71.43 [57.14–78.57] | ||||
Current hormonal therapy | 0.002 | 0.051 | 0.356 | 0.004 | ||||
Tamoxifen | 66.67 [61.11–72.22] | 75.00 [43.75–87.50] | 66.67 [61.11–69.45] | 71.43 [42.86–71.43] | ||||
Exemestane | 63.89 [54.17–68.06] | 59.38 [29.69–100.00] | 66.67 [66.67–77.78] | 71.43 [55.36–78.57] | ||||
Letrozole | 72.22 [66.67–77.78] | 87.50 [56.25–100.00] | 66.67 [66.67–72.22] | 71.43 [71.43–78.57] | ||||
Anastrozole | 61.11 [50.00–66.67] | 100.00 [82.81–100.00] | 66.67 [66.67–73.61] | 57.14 [50.00–71.43] | ||||
Hormonal drug switching | 0.966 | 0.288 | 0.244 | 0.867 | ||||
No | 66.67 [61.11–72.22] | 81.25 [45.31–100.00] | 66.67 [66.67–77.78] | 71.43 [57.14–78.57] | ||||
Yes | 66.67 [61.11–75.00] | 68.75 [46.88–100.00] | 66.67 [66.67–66.67] | 71.43 [60.72–71.43] | ||||
Duration of starting current hormonal therapy | 0.541 | 0.620 | 0.533 | 0.755 | ||||
< 1 year | 66.67 [61.11–72.22] | 75.00 [43.75–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–78.57] | ||||
≥ 1 year | 66.67 [61.11–77.78] | 78.13 [48.44–100.00] | 66.67 [66.67–73.61] | 71.43 [62.50–73.22] | ||||
HER2 status | ||||||||
Negative | 66.67 [61.11–72.22] | 75.00 [50.00–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–78.57] | ||||
Positive | 66.67 [61.11–76.39] | 75.00 [43.75–100.00] | 66.67 [66.67–72.22] | 71.43 [51.79–76.79] | ||||
Disease recurrence | 0.460 | 0.416 | 0.799 | 0.957 | ||||
No | 66.67 [61.11–72.22] | 75.00 [43.75–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–78.57] | ||||
Yes | 66.67 [61.11–77.78] | 81.25 [62.50–100.00] | 66.67 [61.11–83.33] | 71.43 [64.29–71.43] | ||||
Menopausal status | 0.610 | 0.049 | 0.309 | 0.159 | ||||
Premenopause | 66.67 [61.11–72.22] | 75.00 [39.06–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–71.43] | ||||
Postmenopause | 66.67 [61.11–77.78] | 87.50 [62.50–100.00] | 66.67 [66.67–72.22] | 71.43 [57.14–78.57] | ||||